Beckwith-Wiedemann Syndrome

What is Beckwith-Wiedemann syndrome?

Beckwith-Wiedemann syndrome is a rare genetic condition that causes overgrowth in babies and children. It affects about 1 in 10,000 births worldwide. Children with this condition often grow faster and larger than typical, especially during infancy and early childhood.

The syndrome happens when genes that control growth do not work correctly. Specifically, a gene called IGF-2 becomes overactive. IGF-2 stands for insulin-like growth factor 2, a protein that helps cells grow and divide. When the body makes too much IGF-2, growth happens too quickly. This can affect different parts of the body in different ways.

Most children with Beckwith-Wiedemann syndrome grow up healthy with proper monitoring and care. The condition can increase the risk of certain childhood tumors, particularly in the first 8 years of life. Regular screening helps doctors find and treat any problems early. Many symptoms become less noticeable as children grow older.

IGF-2

Checks growth hormone levels
Measures body's growth factor protein
Assesses hormone-related health issues

^$562

Symptoms

Larger than average body size at birth, often weighing more than 8 pounds 13 ounces
Enlarged tongue that may stick out of the mouth
Abdominal wall defects where organs protrude through the belly button area
Creases or pits in the skin near the ears
One side of the body growing larger than the other
Enlarged organs including liver, spleen, or kidneys
Low blood sugar in newborns and infants
Distinctive facial features with a prominent forehead
Red birthmark on the forehead or eyelids

Symptoms vary widely from person to person. Some children have many features of the syndrome while others have only a few. The severity of symptoms also differs greatly among affected individuals.

Causes and risk factors

Beckwith-Wiedemann syndrome results from changes in genes on chromosome 11 that control growth before and after birth. These genes normally work in a balanced way, with some promoting growth and others limiting it. When this balance gets disrupted, overgrowth occurs. Most cases happen randomly, not inherited from parents. About 85% of cases are sporadic, meaning they occur without a family history of the condition.

The genetic changes involve a process called imprinting, where certain genes are turned on or off depending on which parent they came from. When imprinting goes wrong, the IGF-2 gene becomes overactive and produces too much growth factor. Risk factors include older maternal age and use of assisted reproductive technologies like in vitro fertilization. However, most families have no identifiable risk factors. A small percentage of cases, about 10 to 15%, run in families with an autosomal dominant pattern.

How it's diagnosed

Doctors diagnose Beckwith-Wiedemann syndrome based on physical features and genetic testing. A clinical examination looks for characteristic signs like macroglossia, which means enlarged tongue, and abdominal wall defects. Genetic testing confirms the diagnosis by identifying specific changes in chromosome 11. This testing looks at DNA methylation patterns and gene mutations that disrupt normal growth control.

Blood tests may measure IGF-2 levels, which are often elevated in people with this syndrome. However, specialized genetic testing is needed for a definitive diagnosis. Talk to your doctor about testing options if you suspect this condition. Prenatal ultrasound can sometimes detect signs before birth, such as increased size or abdominal wall defects. Early diagnosis helps families prepare for specialized care and monitoring.

Treatment options

Frequent blood sugar monitoring and feeding schedules for infants with hypoglycemia
Surgery to repair abdominal wall defects if present
Tongue reduction surgery if enlarged tongue causes breathing or feeding problems
Regular tumor screening with abdominal ultrasounds every 3 months until age 8
Blood tests to check for tumor markers like alpha-fetoprotein
Physical therapy and orthotics if one side of the body grows differently
Speech therapy to help with communication if tongue size affects speech
Nutritional support and feeding therapy for infants with feeding difficulties
Ongoing monitoring by a team of specialists including geneticists and pediatricians

Frequently asked questions

Beckwith-Wiedemann syndrome is a rare genetic disorder that causes overgrowth in children. It affects about 1 in 10,000 births. The condition results from overactivity of the IGF-2 gene, which controls growth before and after birth. Symptoms include larger body size, enlarged tongue, and increased risk of certain childhood tumors.

The first signs usually appear at birth or in early infancy. Babies are often larger than average, weighing more than 8 pounds 13 ounces. They may have an enlarged tongue, abdominal wall defects, or low blood sugar. Some newborns have distinctive facial features or creases near the ears.

Most cases happen randomly without any family history. About 85% of cases are sporadic, meaning they occur by chance. Only 10 to 15% of cases run in families with an autosomal dominant inheritance pattern. Parents of an affected child have a low risk of having another child with the condition unless genetic testing shows an inherited form.

Blood tests can measure IGF-2 levels, which are often elevated in people with this syndrome. However, genetic testing is needed for a definitive diagnosis. Genetic tests examine DNA from blood samples to look for specific changes in chromosome 11. Your doctor can order specialized testing if Beckwith-Wiedemann syndrome is suspected.

Children with this syndrome have about a 10% risk of developing tumors before age 10. The most common tumors include Wilms tumor in the kidneys and hepatoblastoma in the liver. Regular screening with abdominal ultrasounds every 3 months helps catch tumors early when they are most treatable. The cancer risk decreases significantly after age 8.

Treatment focuses on managing specific symptoms and preventing complications. Infants with low blood sugar need frequent monitoring and feeding. Surgery may repair abdominal wall defects or reduce tongue size if needed. Regular tumor screening continues until age 8, and ongoing care involves multiple specialists including geneticists and pediatricians.

Yes, regular monitoring is essential for early detection of complications. Children need abdominal ultrasounds every 3 months until age 8 to screen for tumors. Blood tests check for tumor markers like alpha-fetoprotein. Growth and development are tracked closely, and any asymmetry in body size is monitored and managed.

Children do not outgrow the genetic condition, but many symptoms improve with age. The rapid growth usually slows down after infancy. Features like enlarged tongue may become less noticeable as the child's face grows. The increased cancer risk decreases significantly after age 8, though lifelong monitoring may still be recommended.

The enlarged tongue, called macroglossia, results from overgrowth of tongue tissue due to excess IGF-2. This growth factor tells cells to grow and divide more than normal. The tongue may stick out of the mouth and cause breathing, feeding, or speech problems. Tongue reduction surgery can help if the size causes significant issues.

Sometimes prenatal ultrasound can detect signs of the condition. Doctors may notice increased fetal size, enlarged organs, or abdominal wall defects during routine scans. However, many cases are not identified until after birth. If prenatal testing suggests the condition, genetic counseling can help families prepare for specialized care at delivery.